94 related articles for article (PubMed ID: 23404300)
1. Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps.
Holterhus PM; Bokelmann J; Riepe F; Heidtmann B; Wagner V; Rami-Merhar B; Kapellen T; Raile K; Quester W; Holl RW;
Diabetes Care; 2013 Jun; 36(6):1507-11. PubMed ID: 23404300
[TBL] [Abstract][Full Text] [Related]
2. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
[TBL] [Abstract][Full Text] [Related]
3. All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates.
Girardot S; Jacquemier P; Mousin F; Rendekeu C; Hardy S; Riveline JP
Diabetes Technol Ther; 2020 Jun; 22(6):476-483. PubMed ID: 32069066
[No Abstract] [Full Text] [Related]
4. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
[TBL] [Abstract][Full Text] [Related]
5. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
8. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094
[TBL] [Abstract][Full Text] [Related]
9. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
11. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
[TBL] [Abstract][Full Text] [Related]
12. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
[TBL] [Abstract][Full Text] [Related]
13. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults.
Bachran R; Beyer P; Klinkert C; Heidtmann B; Rosenbauer J; Holl RW; ; ;
Pediatr Diabetes; 2012 Feb; 13(1):1-5. PubMed ID: 21545675
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
[TBL] [Abstract][Full Text] [Related]
16. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
Klinkert C; Bachran R; Heidtmann B; Grabert M; Holl RW;
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):118-22. PubMed ID: 17973210
[TBL] [Abstract][Full Text] [Related]
17. Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.
Alvarenga CS; La Banca RO; Neris RR; de Cássia Sparapani V; Fuentealba-Torres M; Cartagena-Ramos D; Leal CL; Esper MV; Nascimento LC
BMC Endocr Disord; 2022 Feb; 22(1):43. PubMed ID: 35183150
[TBL] [Abstract][Full Text] [Related]
18. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty.
Cemeroglu AP; Thomas JP; Zande LT; Nguyen NT; Wood MA; Kleis L; Davis AT
Endocr Pract; 2013; 19(5):805-11. PubMed ID: 23757622
[TBL] [Abstract][Full Text] [Related]
19. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
20. Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII).
Nauck MA; Lindmeyer AM; Mathieu C; Meier JJ
J Diabetes Sci Technol; 2021 Mar; 15(2):360-370. PubMed ID: 31633384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
